US Stock MarketDetailed Quotes

CNTB Connect Biopharma

Watchlist
  • 1.1400
  • +0.1700+17.53%
Close Dec 27 16:00 ET
  • 1.1400
  • 0.00000.00%
Post 17:06 ET
62.82MMarket Cap-2.92P/E (TTM)

Connect Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.34%64.85M
20.66%116.51M
229.15%96.56M
81.18%29.34M
16.19M
Selling and administrative expenses
-30.24%14.52M
9.42%20.81M
160.32%19.01M
426.16%7.3M
--1.39M
-General and administrative expense
-30.24%14.52M
9.42%20.81M
160.32%19.01M
426.16%7.3M
--1.39M
Research and development costs
-46.28%51.91M
20.04%96.63M
248.44%80.5M
51.90%23.1M
--15.21M
Other operating expenses
-70.08%-1.58M
68.51%-929K
-175.77%-2.95M
-163.92%-1.07M
---405.33K
Operating profit
44.34%-64.85M
-20.66%-116.51M
-229.15%-96.56M
-81.18%-29.34M
-16.19M
Net non-operating interest income expense
76.69%2.69M
1,592.22%1.52M
127.02%90K
-330.05%-333.06K
144.78K
Non-operating interest income
75.78%2.71M
1,491.75%1.54M
-11.61%97K
-27.97%109.75K
--152.36K
Non-operating interest expense
9.52%23K
200.00%21K
8.89%7K
-15.13%6.43K
--7.57K
Total other finance cost
----
----
----
--436.38K
----
Other net income (expense)
198.75%2.77M
97.34%-2.81M
-17.78%-105.53M
-1,012.60%-89.6M
-8.05M
Gain on sale of security
65.32%2.88M
101.67%1.74M
-16.55%-104.43M
-1,012.60%-89.6M
---8.05M
Special income (charges)
--0
---4.7M
--0
--0
----
-Less:Impairment of capital assets
--0
--4.7M
--0
--0
----
Other non- operating income (expenses)
-167.33%-101K
113.65%150K
---1.1M
----
----
Income before tax
49.59%-59.38M
41.69%-117.79M
-69.36%-202M
-394.89%-119.27M
-24.1M
Income tax
-59.73%120K
12.03%298K
266K
0
0
Net income
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Net income continuous Operations
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
---24.1M
Minority interest income
Net income attributable to the parent company
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Basic earnings per share
49.77%-1.08
44.59%-2.15
-75.48%-3.88
-412.09%-2.2111
-0.4318
Diluted earnings per share
49.77%-1.08
44.59%-2.15
-75.48%-3.88
-412.09%-2.2111
-0.4318
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.34%64.85M20.66%116.51M229.15%96.56M81.18%29.34M16.19M
Selling and administrative expenses -30.24%14.52M9.42%20.81M160.32%19.01M426.16%7.3M--1.39M
-General and administrative expense -30.24%14.52M9.42%20.81M160.32%19.01M426.16%7.3M--1.39M
Research and development costs -46.28%51.91M20.04%96.63M248.44%80.5M51.90%23.1M--15.21M
Other operating expenses -70.08%-1.58M68.51%-929K-175.77%-2.95M-163.92%-1.07M---405.33K
Operating profit 44.34%-64.85M-20.66%-116.51M-229.15%-96.56M-81.18%-29.34M-16.19M
Net non-operating interest income expense 76.69%2.69M1,592.22%1.52M127.02%90K-330.05%-333.06K144.78K
Non-operating interest income 75.78%2.71M1,491.75%1.54M-11.61%97K-27.97%109.75K--152.36K
Non-operating interest expense 9.52%23K200.00%21K8.89%7K-15.13%6.43K--7.57K
Total other finance cost --------------436.38K----
Other net income (expense) 198.75%2.77M97.34%-2.81M-17.78%-105.53M-1,012.60%-89.6M-8.05M
Gain on sale of security 65.32%2.88M101.67%1.74M-16.55%-104.43M-1,012.60%-89.6M---8.05M
Special income (charges) --0---4.7M--0--0----
-Less:Impairment of capital assets --0--4.7M--0--0----
Other non- operating income (expenses) -167.33%-101K113.65%150K---1.1M--------
Income before tax 49.59%-59.38M41.69%-117.79M-69.36%-202M-394.89%-119.27M-24.1M
Income tax -59.73%120K12.03%298K266K00
Net income 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Net income continuous Operations 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M---24.1M
Minority interest income
Net income attributable to the parent company 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Basic earnings per share 49.77%-1.0844.59%-2.15-75.48%-3.88-412.09%-2.2111-0.4318
Diluted earnings per share 49.77%-1.0844.59%-2.15-75.48%-3.88-412.09%-2.2111-0.4318
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.